Showing results (161-170 of 170) with videos related to
Sort By:
Pageof 17
You have reached the last page of results.This site can display upto 170 results.
Journal of the South African Veterinary Association|December 1, 1995
Cyanobacterial (blue-green algae) poisoning of livestock in the western Cape Province of South AfricaA Van Halderen, W R Harding, J C Wessels, et al.Journal of the South African Veterinary Association|December 1, 1996
The effect of selenium supplementation during the early post-mating period on embryonic survival in sheepF E van Niekerk, S W Cloete, E W Heine, et al.The Journal of Pharmacology and Experimental Therapeutics|May 28, 2010
In vivo pharmacological characterization of a novel selective alpha7 neuronal nicotinic acetylcholine receptor agonist ABT-107: preclinical considerations in Alzheimer's diseaseR Scott Bitner, William H Bunnelle, Michael W Decker, et al.Bioorganic & Medicinal Chemistry Letters|October 13, 2005
Synthesis and SAR of highly potent dual 5-HT1A and 5-HT1B antagonists as potential antidepressant drugsAndreas Kling, Udo E W Lange, Helmut Mack, et al.The EMBO Journal|March 17, 1997
Shared and distinct functions of RAGS and ELF-1 in guiding retinal axonsB Monschau, C Kremoser, K Ohta, et al.American Journal of Obstetrics and Gynecology|August 24, 2001
Treatment of complicated Candida vaginitis: comparison of single and sequential doses of fluconazoleJ D Sobel, P S Kapernick, M Zervos, et al.The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|April 8, 2011
Acute inhibition of 11beta-hydroxysteroid dehydrogenase type-1 improves memory in rodent models of cognitionEric G Mohler, Kaitlin E Browman, Victoria A Roderwald, et al.The Journal of Pharmacology and Experimental Therapeutics|July 21, 2012
Pharmacological properties and procognitive effects of ABT-288, a potent and selective histamine H3 receptor antagonistTimothy A Esbenshade, Kaitlin E Browman, Thomas R Miller, et al.The Journal of Pharmacology and Experimental Therapeutics|December 21, 2004
Pharmacological properties of ABT-239 [4-(2-{2-[(2R)-2-Methylpyrrolidinyl]ethyl}-benzofuran-5-yl)benzonitrile]: II. Neurophysiological characterization and broad preclinical efficacy in cognition and schizophrenia of a potent and selective histamine H3 receptor antagonistGerard B Fox, Timothy A Esbenshade, Jia Bao Pan, et al.CNS Neuroscience & Therapeutics|May 17, 2008
Preclinical characterization of A-582941: a novel alpha7 neuronal nicotinic receptor agonist with broad spectrum cognition-enhancing propertiesKarin R Tietje, David J Anderson, R Scott Bitner, et al.Pageof 17